Peter Kotsonis News Today : Breaking News, Live Updates & Top Stories | Vimarsana

UC San Francisco scientists have formed a research alliance with pharmaceutical firm Eli Lilly and Company aimed at better understanding autoimmune diseases and fostering the development of new therapies. Based on the innovative Immunoprofiler model launched at UCSF in 2017, the new initiative, called AutoImmunoprofiler, inherits the most successful aspects of its predecessor and adapts them to the study of autoimmunity. 
Autoimmune diseases such as lupus, inflammatory bowel disease, and type 1 diabetes occur when the immune system attacks the body’s own tissues. While there are some therapies to treat symptoms of these conditions, the underlying causes are largely unknown.     
Matthew “Max” Krummel, PhD ....

Jeans Engleman , David Erle , Caroline Shiboski , Vincent Chan , Eli Lilly , Mark Anderson , Lindsey Criswell , Michael Kattah , Andrew Gross , Maria Dallera , Ajay Nirula , Jeroen Roose , Sarah French , Peter Kotsonis , Matthew Max Krummel , Office Of Strategic Alliances Innovation Ventures , A Research , Our Immunology Team At Lilly , Department Of Orofacial Sciences , School Of Dentistry Sj , Diabetes Center Type , Max Krummel , Distinguished Professor , Maria Dall Era , Orofacial Sciences , Autoimmune Archetypes ,